SRF Limited believes in the long-term growth through balanced and cost-effective debt & equity mix deployed for sustaining and creating value across all capitals. We have a strong mechanism in place to monitor our cash flows and liquidity position, which enables us to identify opportunities for business growth and rationalise costs across all departments. We ensure that an appropriate level of capital for growth projects is allocated along with optimum liquidity for supporting and protecting our business operations under different economic scenarios.
Corporate Governance
Innovation, Research & Development
Operating Cost
Net Debt
Revenue
EBIDTA
EPS
SRF Limited has established internal policies for governing CAPEX proposals and investment rules, that promote sound capital allocation. Our consistent business growth coupled with strong market insights have paved the way for our expansion. This year we have incurred ~₹2,815.78 crore mainly in our Chemical Business for setting up new plants in the agrochemical, capacity enhancement of an existing plant and setting up a range of Specialty Fluoropolymers. These projects are a part of our overall expansion strategy in the Chemicals Business and achieve our future growth aspirations.
In FY23, we recorded a total turnover of ₹14,592 crore which is 17% more than the previous year owing to strong demand mainly from the chemical business. Our PAT increased by 14.5% to ₹2,162.34 crore in FY23. The Company’s EBIDTA increased by 17.8% from the previous year resulting in a strong Balance Sheet.
Our objective is to provide a favourable long-term return on investment. Our EPS has been ₹72.95 and we disbursed two interim dividends of ₹3.6 per share each in the financial year.
CRISIL Ratings has reaffirmed its ‘CRISIL AA+ /Stable/CRISIL A1+’ ratings on the bank facilities and debt instruments of SRF Limited. These ratings continue to reflect a strong business profile driven by market leadership, diversified revenue, high operating efficiency, and a healthy financial profile.
Read the entire Annual Report 2022-23
Capital-Wise Performance
